Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,16 USD | -5,68% | +1,41% | -27,76% |
Omzet 2024 * | 323 mln. 298 mln. | Omzet 2025 * | 420 mln. 387 mln. | Marktkapitalisatie | 409 mln. 377 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -9 mln. -8,3 mln. | Nettowinst (verlies) 2025 * | 49 mln. 45,16 mln. | EV/omzet 2024 * | 0,58 x |
Nettoliquiditeiten 2024 * | 223 mln. 206 mln. | Nettoliquiditeiten 2025 * | 342 mln. 315 mln. | EV/omzet 2025 * | 0,16 x |
K/w-verhouding 2024 * |
-38,4
x | K/w-verhouding 2025 * |
10,9
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,44% |
Recentste transcriptie over Esperion Therapeutics, Inc.
1 dag | -5,68% | ||
1 week | +1,41% | ||
1 maand | +5,88% | ||
3 maanden | -15,29% | ||
6 maanden | +50,00% | ||
Lopend jaar | -27,76% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sheldon Koenig
CEO | Chief Executive Officer | 58 | 15-12-20 |
Director of Finance/CFO | 38 | 01-01-20 | |
JoAnne Foody
CTO | Chief Tech/Sci/R&D Officer | 59 | 28-06-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 52 | 28-04-22 | |
J. Carroll
CHM | Chairman | 74 | 01-06-22 |
Alan Fuhrman
BRD | Director/Board Member | 67 | 16-03-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.02% | 234 M€ | +8,48% | - | |
0.00% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
31-05-24 | 2,16 | -5,68% | 5 947 710 |
30-05-24 | 2,29 | +5,53% | 7 315 179 |
29-05-24 | 2,17 | +3,33% | 5 058 793 |
28-05-24 | 2,1 | -1,41% | 4 533 468 |
24-05-24 | 2,13 | -5,33% | 4 994 789 |
uitgestelde koers Nasdaq, 31 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-27,76% | 409 mln. | |
+40,73% | 739 mld. | |
+32,83% | 598 mld. | |
-6,30% | 353 mld. | |
+15,15% | 318 mld. | |
+4,05% | 285 mld. | |
+15,00% | 240 mld. | |
+9,78% | 210 mld. | |
-5,52% | 206 mld. | |
+6,17% | 164 mld. |